Visilizumab With Tacrolimus and Methotrexate for GvHD Prevention After Allogeneic Hematopoietic Cell Transplantation From Mismatched Unrelated Donors

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2016.330
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Mismatched Related and Unrelated Donors for Allogeneic Hematopoietic Cell Transplantation for Adults With Hematologic Malignancies

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Tacrolimus for Prevention of Graft-Versus-Host Disease After Mismatched Unrelated Donor Cord Blood Transplantation

Bone Marrow Transplantation
TransplantationHematology
1999English

Effect of Early Posttransplantation Tacrolimus Concentration on the Development of Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation From Unrelated Donors

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Comparison of Tacrolimus and Post-Transplant Cyclophosphamide (PTCy) With Tacrolimus and Methotrexate (Tac/Mtx) GVHD Prophylaxis in Patients With AML Undergoing Transplantation From Matched Related or Unrelated Donors

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Prognostic Factors and Outcomes of Severe Gastrointestinal GVHD After Allogeneic Hematopoietic Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2014English

Allogeneic Hematopoietic Stem Cell Transplantation From Alternative Donors for Acquired Aplastic Anemia

Journal of Hematopoietic Cell Transplantation
2016English

Availability of Unrelated Donors for Hematopoietic Stem Cell Transplantation for Hemoglobinopathies

Bone Marrow Transplantation
TransplantationHematology
2003English

Predictors of Overall Survival Among Patients Treated With Sirolimus/Tacrolimus vs Methotrexate/Tacrolimus for GvHD Prevention

Bone Marrow Transplantation
TransplantationHematology
2017English

Decreased Insulin Secretion in Patients Receiving Tacrolimus as GVHD Prophylaxis After Allogeneic Hematopoietic SCT

Bone Marrow Transplantation
TransplantationHematology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy